Literature DB >> 29872147

Body mass index (BMI) trajectories and risk of colorectal cancer in the PLCO cohort.

Rui Zheng1,2, Mulong Du1,2,3, Baoguo Zhang4, Junyi Xin1,2, Haiyan Chu1,2, Min Ni5, Zhengdong Zhang6,7, Dongying Gu8, Meilin Wang9,10.   

Abstract

Obesity is correlated with increased colorectal cancer (CRC) risk, but few studies have investigated lifetime body mass index (BMI) metrics and CRC risk. In a cohort of 139 229 subjects in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, we analysed the effects of life-course BMI trajectories on CRC risk. At 13 years of follow-up, 2031 subjects developed CRC. Compared with subjects who were never overweight/obese, subjects who first exceeded the threshold of 25 kg m-2 at age 20 had a higher CRC risk (HR = 1.28, 95% confidence interval (CI) = 1.11-1.48). A body weight gain of ≥15 kg between 20 and 50 years of age (HR = 1.34, 95% CI = 1.18-1.52) and baseline (HR = 1.24, 95% CI = 1.08-1.43) was significantly associated with increased CRC risk. BMI trajectory analyses revealed that the CRC risk increased gradually over the three BMI trajectories (HR = 1.11-1.27, Ptrend = 0.005) compared with subjects who maintained a normal BMI. Being overweight/obese at the onset of adulthood and BMI trajectories over the lifespan that result in obesity lead to an increased CRC risk.

Entities:  

Mesh:

Year:  2018        PMID: 29872147      PMCID: PMC6035226          DOI: 10.1038/s41416-018-0121-y

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


Introduction

Colorectal cancer (CRC) contributes to the global burden of cancer incidence, and despite declining rates of CRC in some developed countries, CRC incidence remains high.[1] As revealed by epidemiological evidence, excess body fat (i.e., being overweight/obese) is a potentially modifiable lifestyle factor related to CRC.[2] There are several methods to evaluate excess body fat, such as the body mass index (BMI), waist circumference, and waist-to-hip ratio, among others, although BMI is traditionally and widely used as a measurement for easy operation in large epidemiological studies.[3] Previous studies have revealed that individuals with a higher BMI tend to have a higher CRC risk,[4,5] but the relationships among changes to BMI trajectory, cumulative BMI measures during adulthood, and CRC incidence have not been investigated. In this study, we explored the association of CRC risk with age-specific BMI, average BMI, body weight changes, and life-course BMI trajectories in a large prospective cohort study (the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial).

Materials and methods

Study population

The PLCO study is a population-based cohort study that aims to evaluate the accuracy and reliability of screening methods for prostate, lung, colorectal, and ovarian cancer.[6] This study was based on 70 541 subjects in the intervention arm and 68 688 in the control arm. The subjects completed a baseline questionnaire consisting of questions on demographic characteristics and CRC characteristics (Supplementary Materials). The usage of the CRC database in the PLCO study was authorised by the ethics committees of the data providers and Nanjing Medical University.

Ascertainment of CRC

At study entry, subjects were not diagnosed with CRC. CRC cases were ascertained by self-reported annual questionnaires and linkage to the National Death Index (for completeness) and were histologically confirmed via medical record reviews (Supplementary Materials).

Assessment of BMI

BMI was ascertained from self-reported questionnaires completed by the participants in the PLCO study.[7] We divided the BMI values (kg m−2) at the three analysed age points into four categories according to the World Health Organization criteria: underweight (<18.5 kg m−2); normal (18.5 to 24.9 kg m−2, reference); overweight (25 to 29.9 kg m−2); and obese (>30 kg m−2). Weight changes during adulthood were classified as loss (≤−2 kg), stable (>−2 to <5 kg, reference), gain (≥5 to <15 kg), and notable gain (≥15 kg)[8] (Supplementary Materials).

Statistical analysis

Hazard ratios (HRs) and 95% confidence intervals (CIs) for CRC risk were estimated using Cox proportional hazard regression models to evaluate the relationships of age-specific BMI, average BMI, and weight change with CRC risk. To identify subjects with similar patterns of BMI development through the ages of 20 and 50 years and baseline, BMI trajectories based on the latent class growth model were generated with PROC TRAJ (SAS Institute, Inc., Cary, NC, USA).[9] As a result, four trajectory categories (stable normal BMI, normal BMI to overweight, normal BMI to obese, and overweight to obese) were ultimately obtained.[10] All the P values were two-sided, and the results were considered significant at P < 0.05. The analyses were performed using SAS version 9.4 (SAS Institute, Inc.) (Supplementary Materials).

Results

Subjects

This study tracked a total of 139 229 subjects and included 2031 cases. The age at trial entry was 62.6 ± 5.3 years, and the BMIs at the ages of 20 and 50 years and at baseline were 22.1 ± 3.0, 25.9 ± 4.2, and 27.3 ± 4.7 kg m−2, respectively (Supplementary Table S1). In addition, BMI was not observed to interact with the arm, sex, race, and cigarette smoking status (P > 0.05).

Age-specific BMI, average BMI, weight change, and CRC risk

The age-specific BMI analyses suggested that being overweight and obese at various stages of adulthood was more strongly associated with CRC risk, and the lowest HRs were obtained for the baseline measurement, which could be due to an unfavourable metabolic profile (mean age at baseline = 64.3).[11] Specifically, compared with subjects who were never overweight/obese, subjects who first exceeded the threshold of 25 kg m−2 at age 20 had a higher CRC risk (HR = 1.28, 95% CI = 1.11–1.48) (Supplementary Table S2). When modeled continuously, subjects whose average BMI across the three time periods were classified as overweight or obese had an increased CRC risk (HR = 1.22, 1.18, and 1.21 per 5 kg m−2 increase) compared with normal-BMI subjects (Supplementary Table S3). A body weight gain of ≥15 kg between 20 and 50 years of age (HR = 1.34, 95% CI = 1.18–1.52) and baseline (HR = 1.24, 95% CI = 1.08–1.43) conferred a significant increase in CRC risk. Adjusting for the initial weight did not significantly affect the results (Supplementary Table S4).

BMI trajectories and CRC risk

Age-specific BMI trajectories are illustrated in Fig. 1. Compared with subjects that had a normal BMI throughout their adult lifespan, the subjects who progressed from a normal BMI at the onset of adulthood to an obese BMI at baseline had an increased CRC risk (HR = 1.18, 95% CI = 1.03–1.35) (Supplementary Table S5). CRC risk showed a borderline increase in subjects who were overweight (HR = 1.27, 95% CI = 0.99–1.64) at the onset of adulthood and became obese at baseline. This result could be due to the limited sample size in the overweight and obese groups because the Ptrend (Ptrend = 0.005) is statistically significant.
Fig. 1

Latent class growth model of BMI trajectories in the PLCO study. Each trajectory was calculated at any of the three analysed age points (ages of 20 years, 50 years, and baseline). BMI body mass index

Latent class growth model of BMI trajectories in the PLCO study. Each trajectory was calculated at any of the three analysed age points (ages of 20 years, 50 years, and baseline). BMI body mass index Furthermore, stratified analyses by demographic characteristics (randomisation arm, sex, family history of CRC, and cigarette smoking status) showed little connection to BMI and CRC risk, and a subanalysis by CRC characteristics (location, stage, and grade) did not reveal significant associations between BMI and CRC risk (Supplementary Tables S6-S11).

Discussion

The results obtained for age-specific BMI, average BMI, body weight change, and BMI trajectory indicate a significant positive relationship between increased BMI and CRC risk if the subjects became overweight/obese at the onset of adulthood. Prior studies performed a dose–response analysis at a single time point in adulthood to demonstrate that an elevated BMI increases CRC risk.[12] However, the weight of a subject might change over his/her adult life, and weight as a dynamic variable might play a critical role in the onset and progression of CRC.[13] Therefore, our study expanded on prior studies assessing the association of BMI metrics across the adult lifespan with CRC risk. Based on the abovementioned study, a BMI trajectory analysis was performed in this study, and the findings revealed that subjects with a normal or overweight BMI at the onset of adulthood that became obese by baseline have a higher CRC risk, suggesting that being overweight before adulthood could have biological effects on growth or be caused by an increased duration of excess weight.[14] To our knowledge, a cohort study reduces the probability of recall bias, and this study might be suitable for examining the association between different BMI metrics over a subject’s lifespan and CRC risk.[1,7,10] These findings may help young adults reduce CRC risk by focusing on body weight loss. We relied on self-reported body weight and height, which potentially introduced misclassifications in our assessment of BMI and might have limited the ability to investigate the association in this study.[15] Another limitation is that we lack data for other measures of excess body fat, which might provide greater insight into the connection between excess body fat and CRC risk. Additionally, underlying diseases or lifestyle characteristics may cause weight loss, which affects the association between BMI trajectory and CRC risk. In summary, this study suggests that becoming overweight/obese in early adulthood might affect the incidence of CRC and that body weight gain over the adult lifespan is associated with a slightly elevated CRC risk. These findings offer a significant strategy to aid the primary prevention of CRC in subjects with a high BMI starting at early adulthood. Supplementary materials
  14 in total

1.  A prospective study of body mass index, weight change, and risk of cancer in the proximal and distal colon.

Authors:  Ida Laake; Inger Thune; Randi Selmer; Steinar Tretli; Martha L Slattery; Marit B Veierød
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

2.  Colorectal cancer statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Stacey A Fedewa; Dennis J Ahnen; Reinier G S Meester; Afsaneh Barzi; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-03-01       Impact factor: 508.702

3.  Overweight in early adulthood, adult weight change, and risk of type 2 diabetes, cardiovascular diseases, and certain cancers in men: a cohort study.

Authors:  Renée de Mutsert; Qi Sun; Walter C Willett; Frank B Hu; Rob M van Dam
Journal:  Am J Epidemiol       Date:  2014-04-30       Impact factor: 4.897

4.  Neck circumference as a useful marker of obesity: a comparison with body mass index and waist circumference.

Authors:  Mozaffer Rahim Hingorjo; Masood Anwar Qureshi; Asghar Mehdi
Journal:  J Pak Med Assoc       Date:  2012-01       Impact factor: 0.781

5.  Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial.

Authors:  Scott P Kelly; Barry I Graubard; Gabriella Andreotti; Naji Younes; Sean D Cleary; Michael B Cook
Journal:  J Natl Cancer Inst       Date:  2016-10-20       Impact factor: 13.506

Review 6.  The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results.

Authors:  John K Gohagan; Philip C Prorok; Peter Greenwald; Barnett S Kramer
Journal:  Rev Recent Clin Trials       Date:  2015

Review 7.  Obesity and cancer: pathophysiological and biological mechanisms.

Authors:  Andrew G Renehan; Darren L Roberts; Caroline Dive
Journal:  Arch Physiol Biochem       Date:  2008-02       Impact factor: 4.076

Review 8.  Adiposity and cancer at major anatomical sites: umbrella review of the literature.

Authors:  Maria Kyrgiou; Ilkka Kalliala; Georgios Markozannes; Marc J Gunter; Evangelos Paraskevaidis; Hani Gabra; Pierre Martin-Hirsch; Konstantinos K Tsilidis
Journal:  BMJ       Date:  2017-02-28

9.  Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies.

Authors:  Jessica L Petrick; Scott P Kelly; Linda M Liao; Neal D Freedman; Barry I Graubard; Michael B Cook
Journal:  Br J Cancer       Date:  2017-02-14       Impact factor: 7.640

10.  Adult weight change and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition.

Authors:  Krasimira Aleksandrova; Tobias Pischon; Brian Buijsse; Anne M May; Petra H Peeters; H Bas Bueno-de-Mesquita; Mazda Jenab; Veronika Fedirko; Christina C Dahm; Peter D Siersema; Heinz Freisling; Pietro Ferrari; Kim Overvad; Anne Tjønneland; Antonia Trichopoulou; Pagona Lagiou; Androniki Naska; Valeria Pala; Amalia Mattiello; Bodil Ohlsson; Karin Jirström; Timothy J Key; Kay-Tee Khaw; Elio Riboli; Heiner Boeing
Journal:  Eur J Cancer       Date:  2013-07-15       Impact factor: 9.162

View more
  12 in total

1.  Oh GxE! The Complexity of Body Mass Index and Colon Cancer Risk.

Authors:  Joanne Ngeow; Charis Eng
Journal:  J Natl Cancer Inst       Date:  2021-01-04       Impact factor: 13.506

2.  Clinical stages of colorectal cancer diagnosed in obese and overweight individuals in the Polish Colonoscopy Screening Program.

Authors:  Piotr Spychalski; Jarek Kobiela; Paulina Wieszczy; Michał F Kamiński; Jarosław Reguła
Journal:  United European Gastroenterol J       Date:  2019-03-21       Impact factor: 4.623

3.  Addressing Hispanic Obesity Disparities Using a Community Health Worker Model Grounded in Motivational Interviewing.

Authors:  Louis D Brown; Denise Vasquez; Diane I Lopez; Erin M Portillo
Journal:  Am J Health Promot       Date:  2021-11-18

Review 4.  The timing of adiposity and changes in the life course on the risk of cancer.

Authors:  Zhe Fang; Edward L Giovannucci
Journal:  Cancer Metastasis Rev       Date:  2022-07-30       Impact factor: 9.237

5.  Relationship between prediagnostic body mass index trajectory and colorectal adenomas: an analysis of the PLCO cancer screening trial.

Authors:  Linna Luo; Yuying Liu; Zixian Wang; Yue Yan; Chuanbo Xie; Jun Chi; Youzhuo Yang; Jianjun Li; Ruihua Xu
Journal:  Ann Transl Med       Date:  2020-07

Review 6.  Meta-Analysis of the Association between Dietary Inflammatory Index (DII) and Colorectal Cancer.

Authors:  Sharifah Saffinas Syed Soffian; Azmawati Mohammed Nawi; Rozita Hod; Mohd Hasni Ja'afar; Zaleha Md Isa; Huan-Keat Chan; Muhammad Radzi Abu Hassan
Journal:  Nutrients       Date:  2022-04-08       Impact factor: 6.706

7.  Associations of genetic risk, BMI trajectories, and the risk of non-small cell lung cancer: a population-based cohort study.

Authors:  Dongfang You; Danhua Wang; Yaqian Wu; Xin Chen; Fang Shao; Yongyue Wei; Ruyang Zhang; Theis Lange; Hongxia Ma; Hongyang Xu; Zhibin Hu; David C Christiani; Hongbing Shen; Feng Chen; Yang Zhao
Journal:  BMC Med       Date:  2022-06-06       Impact factor: 11.150

8.  Deep Learning Analysis of the Adipose Tissue and the Prediction of Prognosis in Colorectal Cancer.

Authors:  Anqi Lin; Chang Qi; Mujiao Li; Rui Guan; Evgeny N Imyanitov; Natalia V Mitiushkina; Quan Cheng; Zaoqu Liu; Xiaojun Wang; Qingwen Lyu; Jian Zhang; Peng Luo
Journal:  Front Nutr       Date:  2022-05-11

9.  The independent and combined effects of selected risk factors and Arg399Gln XRCC1 polymorphism in the risk of colorectal cancer among an Iranian population.

Authors:  Jamshid Mehrzad; Mahdieh Dayyani; Mohammadreza Erfanian-Khorasani
Journal:  Med J Islam Repub Iran       Date:  2020-07-07

10.  Body Size at Different Ages and Risk of 6 Cancers: A Mendelian Randomization and Prospective Cohort Study.

Authors:  Daniela Mariosa; Karl Smith-Byrne; Tom G Richardson; Pietro Ferrari; Marc J Gunter; Nikos Papadimitriou; Neil Murphy; Sofia Christakoudi; Konstantinos K Tsilidis; Elio Riboli; David Muller; Mark P Purdue; Stephen J Chanock; Rayjean J Hung; Christopher I Amos; Tracy A O'Mara; Pilar Amiano; Fabrizio Pasanisi; Miguel Rodriguez-Barranco; Vittorio Krogh; Anne Tjønneland; Jytte Halkjær; Aurora Perez-Cornago; María-Dolores Chirlaque; Guri Skeie; Charlotta Rylander; Kristin Benjaminsen Borch; Dagfinn Aune; Alicia K Heath; Heather A Ward; Matthias Schulze; Catalina Bonet; Elisabete Weiderpass; George Davey Smith; Paul Brennan; Mattias Johansson
Journal:  J Natl Cancer Inst       Date:  2022-09-09       Impact factor: 11.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.